STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 350 participants.

Also called NCT05785897

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 350 participants (planned count) (from the registry)
Sponsor
IGLESIAS Juan Fernando (from the registry)
Registry
  • NCT NCT05785897
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05785897. Randomized; single masking; primary purpose treatment. Start 2025-11-01 (actual); primary completion 2027-03-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT
Acronym
STARS DAPT
Condition
ST Elevation Myocardial Infarction
Intervention (Device)
Successful primary PCI (percutaneous coronary intervention), defined as primary PCI of the culprit lesion with ≥1 Abluminus NP polymer-free sirolimus-based nanocarrier eluting stent (Concept Medical Inc., India) implantation
Lead sponsor
IGLESIAS Juan Fernando (class: other)
Collaborator
Clinical Trials Unit University of Bern (class: not stated)

Record details

Record id
cardio:ct-nct05785897
Content hash
f28b15b405cb9de33d704cf8d4203b5bb663fc05df1854887801e8f617e6f4e2